All Videos

Expert Seemal R. Desai, M.D., FAAD, highlights new therapeutics that may impact the future of vitiligo management, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Antioxidants can be a valuable part of your vitiligo therapeutic armamentarium, says expert Seemal R. Desai, M.D., FAAD.

Expert Seemal R. Desai, M.D., FAAD, offers practical tips for stabilizing patients who present with active, spreading vitiligo, a topic he discussed at the AAD Virtual Meeting Experience (VMX) in June.

Is your patient’s vitiligo stable, unstable or recalcitrant? Expert Seemal R. Desai, M.D., FAAD, discusses how he classifies disease activity in his practice.

Expert Seemal R. Desai, M.D., FAAD, stresses the importance of defining treatment goals when meeting with vitiligo patients, a topic he covered during his presentation at the AAD Virtual Meeting Experience (VMX) in June.

Expert Christine Ko, M.D., FAAD, discusses case reports exploring the variability of skin manifestation in patients with or suspected of COVID-19 infection.

Most skin manifestations associated with COVID-19 resolve as the disease progresses, says expert Christine Ko, M.D., FAAD. But there is one type of lesion that providers and patients will not want to ignore, she warns.

Learn about the histopathology of skin findings associated with potential COVID-19 infection from expert Christine Ko, M.D., FAAD.

Dr. Randolph Waldman shares details about his overall high patient retention rate and continuing demand for procedures during the ongoing COVID-19 pandemic.

Will the current practice of using telemedicine for acne care have an impact on the future of dermatology? We spoke with Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, on the topic.

Virtual visits may allow providers to focus more on patient education, says Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama.

Dr. Waldman offers an update on processes and protocols for the private practice during the COVID-19 pandemic.

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, discusses how she approaches treating acne via virtual visits after incorporating telemedicine into her practice due to the COVID-19 pandemic.

Is telemedicine a useful tool to treat acne during the COVID-19 pandemic? Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, shares her insights.

Julie Harper, M.D., owner and president of the Dermatology and Skin Cancer Center of Birmingham in Alabama, emphasizes the importance of ensuring timely treatment of acne patients during the COVID-19 crisis.

Dr. Michael Somenek discusses the AAFPRS’s decision to go virtual for their upcoming annual meeting, what’s new this year, and what the attendee experience will be like.

Dr. Joe Niamtu, III, discusses the evolution of aesthetics across specialties over the past two decades, from the introduction of Botox for wrinkles to tumescent liposuction, and the overall benefits of having a multispecialty community working together to advance the space.

Should you close your practice? Retire? Will the mask mandates shift a focus to eye procedures? Is money an issue? Dr. Joe Niamtu shares his perspective.

Cath O'Niell, chief scientific officer at SkinBioTherapeutics and professor of translational dermatology at the University of Manchester, discusses her recent research on developing probiotics to treat psoriasis and other inflammatory skin diseases.

Hema Sundaram, MA, MD, FAAD, highlights an exciting new technology that may change the future of aesthetic therapeutics.

In this video, Hema Sundaram, MA, MD, FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.

Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, MA, MD, FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.

In this video, Hema Sundaram, MA, MD, FAAD, shares pearls on fat grafting from her presentation at the AAD Virtual Meeting Experience (VMX) in June.

Hema Sundaram, MA, MD, FAAD, breaks down how botulinum toxin can be used to treat scars, a topic she discussed during her presentation at the AAD Virtual Meeting Experience (VMX) on June 12.

Dr. Greg Chernoff discusses two recently published studies that examine the benefits of nitric oxide for anti-aging and acne.

Dr. Jeffrey Dover shares what we’ve learned about COVID-19 since reopening the aesthetic practice.

In the final installment of our conversation with Adam Friedman, M.D., FAAD, he details what dermatologists should keep in mind when posting to social media.

Marketing expert Sam Peek discusses the current landscape, including opportunities afforded the aesthetic practice by the pandemic.

In part three of our video interview with Adam Friedman, M.D., FAAD, he discusses some of the benefits and pitfalls of colleague-to-colleague engagement on social media.

In part two of our conversation with Adam Friedman, M.D., FAAD, he offers insight on which patients look for a dermatologist on social media and what types of content produce the most engagement online.